Tandem peptide receptor radionuclide therapy using (90)Y/(177)Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience

INTRODUCTION: One of the concepts of theranostics in nuclear medicine is peptide receptor radionuclide therapy (PRRT), whereby labeled somatostatin analogs are used for imaging and treating inoperable or disseminated neuroendocrine tumors (NET). AIM: The aim of the study was to determine the therape...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Nucl Med Mol Imaging
Autors principals: Kunikowska, Jolanta, Zemczak, Anna, Kołodziej, Maciej, Gut, Paweł, Łoń, Izabela, Pawlak, Dariusz, Mikołajczak, Renata, Kamiński, Grzegorz, Ruchała, Marek, Kos-Kudła, Beata, Królicki, Leszek
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7075861/
https://ncbi.nlm.nih.gov/pubmed/31980909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-04690-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars